Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Drug-induced movement disorders in older adults: an overview for clinical practitioners.

Detweiler MB, Kalafat N, Kim KY.

Consult Pharm. 2007 Feb;22(2):149-65. Review.

PMID:
17367248
2.

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM; American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology.

Circulation. 2007 May 15;115(19):2549-69. Review.

3.

Adherence to medication in patients with dementia: predictors and strategies for improvement.

Arlt S, Lindner R, Rösler A, von Renteln-Kruse W.

Drugs Aging. 2008;25(12):1033-47. doi: 10.2165/0002512-200825120-00005. Review.

PMID:
19021302
4.

Movement disorders in the older patient: differential diagnosis and general management.

Baron MS.

Cleve Clin J Med. 2005 Oct;72 Suppl 3:S38-51. Review.

PMID:
16265942
5.

Recognizing the rising impact of diabetes in seniors and implications for its management.

Drab SR.

Consult Pharm. 2009 Jun;24 Suppl B:5-10. Review.

PMID:
19555130
6.

Practical aspects of drug treatment in elderly patients with mobility problems.

Thwaites JH.

Drugs Aging. 1999 Feb;14(2):105-14. Review.

PMID:
10084364
7.

Screening older adults for impaired visual acuity: a review of the evidence for the U.S. Preventive Services Task Force.

Chou R, Dana T, Bougatsos C.

Ann Intern Med. 2009 Jul 7;151(1):44-58, W11-20. Review.

PMID:
19581646
8.

Diagnosis and management of geriatric insomnia: a guide for nurse practitioners.

Krishnan P, Hawranik P.

J Am Acad Nurse Pract. 2008 Dec;20(12):590-9. doi: 10.1111/j.1745-7599.2008.00366.x. Review.

PMID:
19120590
9.

Inappropriate sexual behaviors in cognitively impaired older individuals.

Guay DR.

Am J Geriatr Pharmacother. 2008 Dec;6(5):269-88. doi: 10.1016/j.amjopharm.2008.12.004. Review.

PMID:
19161930
10.

Improving effectiveness in communicating risk to patients.

Burkiewicz JS, Vesta KS, Hume AL.

Consult Pharm. 2008 Jan;23(1):37-43. Review.

PMID:
18284317
11.

Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.

Rojas-Fernandez CH, Moorhouse P.

Ann Pharmacother. 2009 Jul;43(7):1310-23. doi: 10.1345/aph.1L703. Epub 2009 Jul 7. Review.

PMID:
19584390
12.

Drug therapy implications on activity: a focus on the elderly patient.

Simonson W, Florkowski WJ.

Nurse Pract Forum. 1996 Dec;7(4):179-84. Review.

PMID:
9043298
13.

Pharmacological management of glycemic control in the geriatric patient with type 2 diabetes mellitus.

Neumiller JJ, Setter SM, Gates BJ, Sonnett TE, Dobbins EK, Campbell K.

Consult Pharm. 2009 Jan;24(1):45-63. Review.

PMID:
19275459
14.

Polypharmacy in elderly patients.

Hajjar ER, Cafiero AC, Hanlon JT.

Am J Geriatr Pharmacother. 2007 Dec;5(4):345-51. doi: 10.1016/j.amjopharm.2007.12.002. Review.

PMID:
18179993
15.

Interventions for promoting mobility in community-dwelling older adults.

Yeom HA, Keller C, Fleury J.

J Am Acad Nurse Pract. 2009 Feb;21(2):95-100. doi: 10.1111/j.1745-7599.2008.00390.x. Review.

PMID:
19228247
16.

When oral agents fail: optimizing insulin therapy in the older adult.

Meece J.

Consult Pharm. 2009 Jun;24 Suppl B:11-7. Review.

PMID:
19555131
17.

Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence.

Ali R, Alexander KP.

Am J Geriatr Pharmacother. 2007 Mar;5(1):52-63. Review.

PMID:
17608248
18.

Movement disorders.

Harris MK, Shneyder N, Borazanci A, Korniychuk E, Kelley RE, Minagar A.

Med Clin North Am. 2009 Mar;93(2):371-88, viii. doi: 10.1016/j.mcna.2008.09.002. Review.

PMID:
19272514
19.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
20.

Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.

Peak AS, Sheller A.

Ann Pharmacother. 2007 Sep;41(9):1481-5. Epub 2007 Aug 7. Review.

PMID:
17684032

Supplemental Content

Support Center